22-43928850-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_025225.3(PNPLA3):​c.447C>T​(p.Pro149Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.232 in 1,606,722 control chromosomes in the GnomAD database, including 47,854 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4553 hom., cov: 30)
Exomes 𝑓: 0.23 ( 43301 hom. )

Consequence

PNPLA3
NM_025225.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.31
Variant links:
Genes affected
PNPLA3 (HGNC:18590): (patatin like phospholipase domain containing 3) The protein encoded by this gene is a triacylglycerol lipase that mediates triacylglycerol hydrolysis in adipocytes. The encoded protein, which appears to be membrane bound, may be involved in the balance of energy usage/storage in adipocytes. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 22-43928850-C-T is Benign according to our data. Variant chr22-43928850-C-T is described in ClinVar as [Benign]. Clinvar id is 341933.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.31 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PNPLA3NM_025225.3 linkuse as main transcriptc.447C>T p.Pro149Pro synonymous_variant 3/9 ENST00000216180.8 NP_079501.2 Q9NST1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PNPLA3ENST00000216180.8 linkuse as main transcriptc.447C>T p.Pro149Pro synonymous_variant 3/91 NM_025225.3 ENSP00000216180.3 Q9NST1-1

Frequencies

GnomAD3 genomes
AF:
0.228
AC:
34587
AN:
151580
Hom.:
4551
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.140
Gnomad AMI
AF:
0.273
Gnomad AMR
AF:
0.424
Gnomad ASJ
AF:
0.211
Gnomad EAS
AF:
0.387
Gnomad SAS
AF:
0.236
Gnomad FIN
AF:
0.220
Gnomad MID
AF:
0.256
Gnomad NFE
AF:
0.226
Gnomad OTH
AF:
0.264
GnomAD3 exomes
AF:
0.278
AC:
69774
AN:
251164
Hom.:
11853
AF XY:
0.267
AC XY:
36269
AN XY:
135764
show subpopulations
Gnomad AFR exome
AF:
0.137
Gnomad AMR exome
AF:
0.550
Gnomad ASJ exome
AF:
0.219
Gnomad EAS exome
AF:
0.381
Gnomad SAS exome
AF:
0.221
Gnomad FIN exome
AF:
0.226
Gnomad NFE exome
AF:
0.229
Gnomad OTH exome
AF:
0.280
GnomAD4 exome
AF:
0.233
AC:
338558
AN:
1455024
Hom.:
43301
Cov.:
35
AF XY:
0.232
AC XY:
167976
AN XY:
724274
show subpopulations
Gnomad4 AFR exome
AF:
0.132
Gnomad4 AMR exome
AF:
0.536
Gnomad4 ASJ exome
AF:
0.218
Gnomad4 EAS exome
AF:
0.418
Gnomad4 SAS exome
AF:
0.224
Gnomad4 FIN exome
AF:
0.227
Gnomad4 NFE exome
AF:
0.218
Gnomad4 OTH exome
AF:
0.230
GnomAD4 genome
AF:
0.228
AC:
34593
AN:
151698
Hom.:
4553
Cov.:
30
AF XY:
0.233
AC XY:
17300
AN XY:
74118
show subpopulations
Gnomad4 AFR
AF:
0.139
Gnomad4 AMR
AF:
0.423
Gnomad4 ASJ
AF:
0.211
Gnomad4 EAS
AF:
0.386
Gnomad4 SAS
AF:
0.237
Gnomad4 FIN
AF:
0.220
Gnomad4 NFE
AF:
0.226
Gnomad4 OTH
AF:
0.261
Alfa
AF:
0.219
Hom.:
1992
Bravo
AF:
0.245
Asia WGS
AF:
0.296
AC:
1026
AN:
3478
EpiCase
AF:
0.238
EpiControl
AF:
0.242

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxJun 07, 2021- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJul 25, 2019The p.Pro149Pro variant in PNPLA3 is classified as benign because it does not alter an amino acid residue, is not located within the splice consensus site, and computational splice prediction tools do not predict an impact on splicing. It has been identified in 55% (19436/35384, including 5584 homozygous observations) of Latino chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1, BP4, BP7. -
NAFLD1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.28
DANN
Benign
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs738408; hg19: chr22-44324730; COSMIC: COSV53377681; COSMIC: COSV53377681; API